Jean Treacy - Academia.edu (original) (raw)
Uploads
Papers by Jean Treacy
Seminars in Oncology Nursing, 2000
W~tten ma~Is, a~ Cont~n~ttes to better patient ~tcome& Inadequate health literacy and ot~ barrier... more W~tten ma~Is, a~ Cont~n~ttes to better patient ~tcome& Inadequate health literacy and ot~ barriers present challenges ~ proriding effective patient education.
Journal of Oncology Practice, 2005
Purpose: Most chemotherapy (CT) administration occurs in routine care settings, yet little is kno... more Purpose: Most chemotherapy (CT) administration occurs in routine care settings, yet little is known about treatmentrelated toxicity outside of clinical trials. To examine trends in toxicity, modify practice, and establish benchmarks for severe toxicity in a community cancer center we created a prospective registry of all treatment-related hospitalizations at the North Shore Medical Center Cancer Center, a community-based cancer facility in Peabody, MA. Methods: Eligible population consisted of all adult cancer patients admitted to the hospital within 30 days of their last CT administration. Each admission was reviewed by a panel of hospital staff to determine whether admission was treatment-related. Information on admission was collected using a standard form. Results: Between October 2001 and December 2003, there were 365 hospitalizations among patients receiving CT, 117 (32%) of which were deemed treatment-related. The median age of the cohort with treatment-related toxicity was 67 years, and 41% were male. Most frequent diagnoses were non-Hodgkin's lymphoma (23%) and colorectal cancer (21%), with 49% of the patients receiving treatment with palliative intent. The most common reasons for admission were gastrointestinal toxicity or infection. The mean length of stay was 7.1 days. Seven patients (6%) died during hospitalization. When the registry was reviewed to identify areas where care may be improved, several admissions for decadronrelated hyperglycemia in nondiabetic patients with myeloma were noted. This led to introduction of glucose monitoring guidelines with no subsequent admissions for this toxicity since then. Conclusions: About one third of hospital admissions in patients receiving CT are treatment-related and most occur in patients with advanced disease. Collection of data on toxicity in the routine care setting is feasible and may facilitate quality improvement.
Seminars in Oncology Nursing, 2000
W~tten ma~Is, a~ Cont~n~ttes to better patient ~tcome& Inadequate health literacy and ot~ barrier... more W~tten ma~Is, a~ Cont~n~ttes to better patient ~tcome& Inadequate health literacy and ot~ barriers present challenges ~ proriding effective patient education.
Journal of Oncology Practice, 2005
Purpose: Most chemotherapy (CT) administration occurs in routine care settings, yet little is kno... more Purpose: Most chemotherapy (CT) administration occurs in routine care settings, yet little is known about treatmentrelated toxicity outside of clinical trials. To examine trends in toxicity, modify practice, and establish benchmarks for severe toxicity in a community cancer center we created a prospective registry of all treatment-related hospitalizations at the North Shore Medical Center Cancer Center, a community-based cancer facility in Peabody, MA. Methods: Eligible population consisted of all adult cancer patients admitted to the hospital within 30 days of their last CT administration. Each admission was reviewed by a panel of hospital staff to determine whether admission was treatment-related. Information on admission was collected using a standard form. Results: Between October 2001 and December 2003, there were 365 hospitalizations among patients receiving CT, 117 (32%) of which were deemed treatment-related. The median age of the cohort with treatment-related toxicity was 67 years, and 41% were male. Most frequent diagnoses were non-Hodgkin's lymphoma (23%) and colorectal cancer (21%), with 49% of the patients receiving treatment with palliative intent. The most common reasons for admission were gastrointestinal toxicity or infection. The mean length of stay was 7.1 days. Seven patients (6%) died during hospitalization. When the registry was reviewed to identify areas where care may be improved, several admissions for decadronrelated hyperglycemia in nondiabetic patients with myeloma were noted. This led to introduction of glucose monitoring guidelines with no subsequent admissions for this toxicity since then. Conclusions: About one third of hospital admissions in patients receiving CT are treatment-related and most occur in patients with advanced disease. Collection of data on toxicity in the routine care setting is feasible and may facilitate quality improvement.